Medical News

RSS

Alfred biomodelling creates life like hobbit

Pioneering Alfred technology is being put to good use in understanding where we come from, in the fields of Anthropology and Palaeontology.

26 Jul 2005

New national cytology training programme established in New Zealand

A new nationally-coordinated training programme for pathologists, scientists and technicians involved in processing and interpreting cervical smears is to be established. The programme will be based in Christchurch with training taking place in main centres across New Zealand.

26 Jul 2005

GenoMed submits 50th provisional patent application

GenoMed announced today that the Company has submitted its 50th provisional patent application, a major milestone in any development stage company. GenoMed has so far been awarded two patents, one for treating acute kidney failure without dialysis, and another for hastening lung maturation in prematurely born infants.

26 Jul 2005

Cancer vaccine combined with hormone-deprivation therapy can help patients with recurrence of prostate cancer

A new study finds that a cancer vaccine combined with hormone-deprivation therapy can help patients with recurrence of prostate cancer. The results of this clinical trial, led by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health, appear in the August 2005 issue of the Journal of Urology.

26 Jul 2005

Molecular link between a viral infection and development of a common and fatal form of liver cancer

Researchers at The University of Texas M. D. Anderson Cancer Center have uncovered a crucial molecular link between a viral infection and development of a common and fatal form of liver cancer. In the process, they have identified a possible way to treat this disease as well as a number of other cancers.

26 Jul 2005

Loyola researchers hope that zoledronic acid will be effective and safe for patients with inflammatory bowel diseases (IBD)

Researchers at the Osteoporosis and Metabolic Bone Disease Center and the Division of Gastroenterology at Loyola University Health System are studying a once-yearly, 15-minute infusion of an intravenous (IV) medication in patients with osteopenia (low bone mass) and inflammatory bowel diseases (IBD) that, if proven effective, may be considered the standard of treatment.

26 Jul 2005

Neuroscientists identify how the brain processes and stores emotional experiences as long-term memories

The research, performed on rats, could help neuroscientists better understand why emotionally arousing events are remembered over longer periods than emotionally neutral events, and may ultimately find application in treatments for conditions such as post-traumatic stress disorder.

26 Jul 2005

TEVA to acquire IVAX for $7.4 billion

TEVA Pharmaceutical Industries and IVAX Corporation have jointly announced that they have signed a definitive agreement providing for the acquisition of IVAX by TEVA.

26 Jul 2005

Acetaminophen, when taken as directed, is safe for patients with liver disease

Contrary to common perception, clinical data demonstrate that acetaminophen is an appropriate pain relief choice for patients with chronic liver disease. According to a systematic literature review of the data, which is published in the current issue of the American Journal of Therapeutics, there is no evidence that acetaminophen at therapeutic doses aggravates liver disease.

26 Jul 2005

Bird flu could spread to Europe on wings of Asian wild geese

Migratory wild birds from China, which were found to have contracted bird flu from poultry, could potentially spread the disease to Europe, as well as Australia, Chinese scientists report.

26 Jul 2005

Analysis of the Phase I/II clinical trial of HIV drug candidate PA-457

V.I. Technologies (Vitex) and collaborators at the University at Buffalo's School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, today presented a detailed analysis of the Phase I/II clinical trial of its HIV drug candidate PA-457 at the 3rd International AIDS Society (IAS) Conference on HIV Pathogenesis and Treatment in Rio de Janeiro, Brazil.

26 Jul 2005

Fat-dissolving fads: Too good to be true?

The search for a non-surgical method to get rid of unwanted fat is not new - and neither is 'mesotherapy', a technique which claims to dissolve fat by injections of medications or vitamins, minerals and herbs.

26 Jul 2005

Leg strength gets a push from training technique

A pair of studies published recently in Medicine & Science in Sports & Exercise (MSSE), the official scientific journal of the American College of Sports Medicine (ACSM), underscore the relevance of sports and exercise research to this year’s Tour de France. One study accurately predicted Lance Armstrong’s time in a stage of the 2004 race, while another points to an effective training technique for aspiring cyclists.

26 Jul 2005

Doctors not responsible for patient gaps

Australian Medical Association (AMA) President, Dr Mukesh Haikerwal, said it was mischievous of the Australian Health Industry Association (AHIA) to be running around in the media this morning blaming doctors for private patients being confronted with high gap payments.

26 Jul 2005

BSD Medical receives notice of allowance for new patent

BSD Medical today announced that the company has received "official notice of allowance" for a new patent that is expected to be issued by the U.S. Patent Office.

26 Jul 2005

Working class twins fare worse than their professional sibs on blood pressure, cholesterol and self-rated health

Nancy Krieger, professor of society, human development and health at the Harvard School of Public Health and colleagues, compared the health status, education levels and adult occupational class among women who were identical twins and who lived together through adolescence, to demonstrate that adult socioeconomic conditions affect adult health, above and beyond genetics and early life conditions.

26 Jul 2005

Does aspirin work equally well for everyone?

We all know that aspirin can help prevent a heart attack or stroke, but does aspirin work equally well for everyone? A growing amount of medical evidence says no. One reason emerging to explain this difference is that some people fail to achieve an adequate response to the drug.

26 Jul 2005

First large-scale effort to sequence the flu genome

Multiple strains of the flu virus, circulating in a population at the same time, can reshuffle their genes and create a new virus, one capable of infecting many more people, according to a new study in the open-access journal PLoS Biology.

26 Jul 2005

Human papillomavirus (HPV) genotyping can benefit clinical practice

A study published in the current issue of the Journal of the National Cancer Institute (JNCI) concludes that genotyping of specific high-risk types of the human papillomavirus (HPV), the cause of virtually all cases of cervical cancer, can benefit clinical practice by enabling more focused attention on women who are at highest risk, announced Digene Corporation.

26 Jul 2005

Investigational vaccine against Clostridium difficile

Acambis has announced that earlier this month it started a Phase I clinical trial of its investigational vaccine against Clostridium difficile (C. difficile).

26 Jul 2005